Article info
PostScript
Correspondence
Presence of dual anti-MPO and anti-PR3 antibodies in Systemic Lupus Erythematosus/ANCA-Associated Vasculitis
- Correspondence to Dr Therese Boyle, Department of Clinical Immunology and Allergy, Royal North Shore Hospital, Sydney, NSW 2065, Australia; thereseboyle{at}hotmail.com
Citation
Presence of dual anti-MPO and anti-PR3 antibodies in Systemic Lupus Erythematosus/ANCA-Associated Vasculitis
Publication history
- Received October 1, 2019
- Revised March 29, 2020
- Accepted May 19, 2020
- First published June 8, 2020.
Online issue publication
December 21, 2020
Article Versions
- Previous version (18 September 2020).
- Previous version (18 September 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.